Φορτώνει......
Immune checkpoint inhibitors in cancer therapy
In recent years immune checkpoint inhibitors have garnered attention as being one of the most promising types of immunotherapy on the horizon. There has been particular focus on the immune checkpoint molecules, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) whic...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Biomed Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Editorial Department of Journal of Biomedical Research
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163118/ https://ncbi.nlm.nih.gov/pubmed/28866656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.31.20160168 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|